(5-甲基-1H-吲唑-3-基)甲醇 | 518990-04-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并吡唑类
• 中文名称: (5-甲基-1H-吲唑-3-基)甲醇
• 英文名称: (5-Methyl-1H-indazol-3-yl)methanol
• 英文别名: (5-methyl-2H-indazol-3-yl)methanol
• CAS: 518990-04-0
• 化学式: C₉H₁₀N₂O
• mdl: MFCD11007903
• 分子量: 162.19
• InChiKey: GAEAFGIMXQRNTK-UHFFFAOYSA-N

物化性质

• 沸点：
  386.9±27.0 °C(Predicted)
• 密度：
  1.295±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.222
• 拓扑面积：
  48.9
• 氢给体数：
  2
• 氢受体数：
  2

安全信息

• 海关编码：
  2933990090

文献信息

• Benzimidazoles
  申请人：Edwards L. Michael

  公开号：US20060014756A1

  公开（公告）日：2006-01-19

  The invention is directed to physiologically active compounds of the general formula (Ix) and compositions containing such compounds, and their prodrugs, and pharmaceutically acceptable salts and solvates of such compounds and their prodrugs, as well as to novel compounds within the scope of formula (Ix), and to processes for their preparation. Such compounds and compositions have valuable pharmaceutical properties, in particular the ability to inhibit kinases.

  本发明涉及一般式（Ix）的生理活性化合物及含有这种化合物的组合物，以及它们的前药、药学上可接受的盐和溶剂化物，还涉及在式（Ix）范围内的新化合物和它们的制备方法。这种化合物和组合物具有有价值的药物性质，特别是抑制激酶的能力。
• ANTICANCER AGENT
  申请人：Nagano Tetsuo

  公开号：US20130102776A1

  公开（公告）日：2013-04-25

  An anticancer agent comprising a compound represented by the formula (I) [R 1 represents hydrogen atom, hydroxyl group, a C 1-6 alkoxy group and the like; R 2 and R 3 represents hydrogen atom, a halogen atom, a C 1-6 alkyl group and the like; R 4 represents hydrogen atom, a C 1-6 alkyl group, a C 1-6 alkylsulfonyl group and the like; R 5 represents hydrogen atom or a substituent; represents a single bond or a double bond; R 6 and R 7 represents hydrogen atom, a C 1-6 alkyl group and the like; R 8 represents hydrogen atom, a C 1-6 alkyl group and the like; A represents —O—, —S—, or —CH 2 —; D represents —C═ or —N═; X represents methylene group, —O—, or —CO—; Q represents —N═ or —C(R 8 )═; and Y represents a heterocyclic group or amino group], which shows a superior inhibitory activity against pim-1 kinase.

  一种抗癌剂，包括由式(I)所表示的化合物[其中R1代表氢原子、羟基、C1-6烷氧基等；R2和R3代表氢原子、卤原子、C1-6烷基等；R4代表氢原子、C1-6烷基、C1-6烷基磺酰基等；R5代表氢原子或取代基；代表单键或双键；R6和R7代表氢原子、C1-6烷基等；R8代表氢原子、C1-6烷基等；A代表—O—、—S—或—CH2—；D代表—C═或—N═；X代表亚甲基、—O—或—CO—；Q代表—N═或—C(R8)═；Y代表杂环基或氨基]，该化合物对pim-1激酶表现出优异的抑制活性。
• BENZIMIDAZOLES AND ANALOGUES AND THEIR USE AS PROTEIN KINASES INHIBITORS
  申请人：Aventis Pharmaceuticals Inc.

  公开号：EP1441725A1

  公开（公告）日：2004-08-04
• US6897208B2
  申请人：——

  公开号：US6897208B2

  公开（公告）日：2005-05-24
• US8288425B2
  申请人：——

  公开号：US8288425B2

  公开（公告）日：2012-10-16